Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progress in therapy for testicular tumors].

Yoichi Mizutani1, Terukazu Nakamura, Takeshi Nomoto

  • 1Dept. of Urology, Kyoto Prefectural University of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 18, 2006
PubMed
Summary

Most testicular tumors are cured with chemotherapy, but refractory cases require new treatments. This review covers emerging salvage chemotherapy options for advanced testicular tumors, including novel agents and high-dose therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible cystogenesis in juvenile primate ADPKD models: evidence from PKD1 heterozygous monkeys.

Human molecular genetics·2026
Same author

Association Between Maternal Bladder Descent Angle and Urinary Incontinence in Late Pregnancy: A Transperineal Ultrasonography Study.

Lower urinary tract symptoms·2026
Same author

Adverse Events in Testicular Cancer Survivors Using EORTC QLQ-TC26: A Multi-Institutional, Cross-Sectional Study in Japan.

International journal of urology : official journal of the Japanese Urological Association·2025
Same author

Urinary function changes during pregnancy assessed by frequency volume charts in a prospective longitudinal study.

Scientific reports·2025
Same author

Physical and biological properties of a novel anti-adhesive punctate uneven gelatin film.

PloS one·2025
Same author

Comorbidities in Japanese testicular cancer survivors: A multi-institutional, cross-sectional study.

International journal of urology : official journal of the Japanese Urological Association·2024

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Metastatic testicular tumors have an 80% cure rate with standard cisplatin chemotherapy and surgery.
  • A significant 20% of patients present with advanced or refractory testicular tumors, posing a major clinical challenge.

Purpose of the Study:

  • To review recent advancements in chemotherapy for refractory testicular tumors.
  • To highlight novel salvage chemotherapy strategies and agents.

Main Methods:

  • Literature review of recent studies on testicular tumor chemotherapy.
  • Focus on salvage chemotherapy regimens for advanced and refractory cases.

Main Results:

  • Emerging salvage chemotherapy regimens show promise for previously untreatable testicular tumors.

Related Experiment Videos

  • Novel anticancer agents like paclitaxel, gemcitabine, irinotecan, docetaxel, and oxaliplatin are being investigated.

    • Conclusions:

    • New chemotherapy modalities offer hope for patients with refractory testicular tumors.
    • Continued research into novel agents and high-dose chemotherapy is crucial for improving outcomes in advanced testicular cancer.